These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16952205)

  • 21. Effect of midazolam versus propofol sedation on markers of neurological injury and outcome after isolated severe head injury: a pilot study.
    Ghori KA; Harmon DC; Elashaal A; Butler M; Walsh F; O'Sullivan MG; Shorten GD
    Crit Care Resusc; 2007 Jun; 9(2):166-71. PubMed ID: 17536986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
    Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R
    Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
    Farber RH; Burke PJ
    Curr Med Res Opin; 2008 Mar; 24(3):837-46. PubMed ID: 18257978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
    Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone.
    Boyle J; Trick L; Johnsen S; Roach J; Rubens R
    Hum Psychopharmacol; 2008 Jul; 23(5):385-97. PubMed ID: 18350566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of oral chloral hydrate and sublingual midazolam sedation for echocardiogram in children.
    Layangool T; Sangtawesin C; Kirawittaya T; Prompan W; Attachoo A; Pechdamrongsakul A; Intasorn Y; Hanchai P; Ounjareon C; Noisang P
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S45-52. PubMed ID: 19255992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of propofol with pentobarbital/midazolam/fentanyl sedation for magnetic resonance imaging of the brain in children.
    Pershad J; Wan J; Anghelescu DL
    Pediatrics; 2007 Sep; 120(3):e629-36. PubMed ID: 17698968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and driving ability following low-dose propofol sedation.
    Horiuchi A; Nakayama Y; Katsuyama Y; Ohmori S; Ichise Y; Tanaka N
    Digestion; 2008; 78(4):190-4. PubMed ID: 19092246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The cognitive effect of alprazolam in healthy volunteers].
    Drabant S; Tömlo J; Tóth M; Péterfai E; Klebovich I
    Acta Pharm Hung; 2006; 76(1):25-31. PubMed ID: 17094673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB
    Hum Psychopharmacol; 2007 Dec; 22(8):559-66. PubMed ID: 17902186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bispectral index-guided intraoperative sedation with dexmedetomidine and midazolam infusion in outpatient cataract surgery.
    Apan A; Doganci N; Ergan A; Büyükkoçak U
    Minerva Anestesiol; 2009 May; 75(5):239-44. PubMed ID: 19088698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects--extrapolation of potential risk for acute trauma trials.
    Freilich D; Pearce LB; Pitman A; Greenburg G; Berzins M; Bebris L; Ahlers S; McCarron R
    J Trauma; 2009 Feb; 66(2):365-76. PubMed ID: 19204509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal midazolam: a comparison of two delivery devices in human volunteers.
    Dale O; Nilsen T; Loftsson T; Hjorth Tønnesen H; Klepstad P; Kaasa S; Holand T; Djupesland PG
    J Pharm Pharmacol; 2006 Oct; 58(10):1311-8. PubMed ID: 17034653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions.
    Greenblatt DJ; Ehrenberg BL; Culm KE; Scavone JM; Corbett KE; Friedman HL; Harmatz JS; Shader RI
    J Clin Pharmacol; 2004 Jun; 44(6):605-11. PubMed ID: 15145968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of lorazepam on visual perceptual abilities.
    Pompéia S; Pradella-Hallinan M; Manzano GM; Bueno OF
    Hum Psychopharmacol; 2008 Apr; 23(3):183-92. PubMed ID: 18318455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine.
    Fredrickson A; Snyder PJ; Cromer J; Thomas E; Lewis M; Maruff P
    Hum Psychopharmacol; 2008 Jul; 23(5):425-36. PubMed ID: 18421801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study.
    Adachi JD; Faraawi RY; O'Mahony MF; Nayar A; Massaad R; Evans JK; Yacik C
    Clin Ther; 2009 Aug; 31(8):1747-53. PubMed ID: 19808133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.